ANISOMYCIN AND RAPAMYCIN DEFINE AN AREA UPSTREAM OF P70 85(S6K) CONTAINING A BIFURCATION TO HISTONE H3-HMG-LIKE PROTEIN-PHOSPHORYLATION ANDC-FOS C-JUN INDUCTION/
E. Kardalinou et al., ANISOMYCIN AND RAPAMYCIN DEFINE AN AREA UPSTREAM OF P70 85(S6K) CONTAINING A BIFURCATION TO HISTONE H3-HMG-LIKE PROTEIN-PHOSPHORYLATION ANDC-FOS C-JUN INDUCTION/, Molecular and cellular biology, 14(2), 1994, pp. 1066-1074
Anisomycin, a translational inhibitor, synergizes with growth factors
and phorbol esters to superinduce c-fos and c-jun by a number mechanis
ms, one of which is its ability to act as a potent signalling agonist,
producing strong, prolonged activation of the same nuclear responses
as epidermal growth factor or tetradecanoyl phorbol acetate. These res
ponses include the phosphorylation of pp33, which exists in complexed
and chromatin-associated forms, and of histone H3 and an HMG-like prot
ein. By peptide mapping and microsequencing, we show here that pp33 is
the phosphoprotein S6, present in ribosomes and in preribosomes in th
e nucleolus. Ablation of epidermal growth factor-, tetradecanoyl phorb
ol acetate-, or anisomycin-stimulated S6 phosphorylation by using the
p70/85(S6k) inhibitor rapamycin has no effect on histone H3 and HMG-li
ke protein phosphorylation or on the induction and superinduction of c
-fos and c-jun. Further, [S-35]methionine-labelling and immunoprecipit
ation studies show that the ablation of S6 phosphorylation has no disc
ernible effect on translation in general or translation of newly induc
ed c-fos transcripts. Finally, we show that anisomycin augments and pr
olongs S6 phosphorylation not by blocking S6 phosphatases but by susta
ined activation of p70/85(S6k). These results suggest the possible use
of anisomycin and rapamycin to define upstream and downstream boundar
ies of an area of signalling above p70/85(S6k) which contains a bifurc
ation that produced histone H3-HMG-like protein phosphorylation and c-
fos-c-jun induction in the nucleus.